Should I buy or sell Nature's Sunshine Products stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NATR shares. View NATR analyst ratings or view top-rated stocks .

What is Nature's Sunshine Products' stock price target for 2024?

1 Wall Street analysts have issued 12 month price objectives for Nature's Sunshine Products' shares. Their NATR share price targets range from $24.00 to $24.00. On average, they predict the company's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for NATR or view top-rated stocks among Wall Street analysts .

How have NATR shares performed in 2024?

Nature's Sunshine Products' stock was trading at $17.29 at the start of the year. Since then, NATR stock has increased by 11.6% and is now trading at $19.29. View the best growth stocks for 2024 here .

When is Nature's Sunshine Products' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our NATR earnings forecast .

How were Nature's Sunshine Products' earnings last quarter?

Nature's Sunshine Products, Inc. (NASDAQ:NATR) released its quarterly earnings data on Tuesday, March, 12th. The company reported $0.45 earnings per share (EPS) for the quarter. The company had revenue of $108.94 million for the quarter. Nature's Sunshine Products had a net margin of 3.39% and a trailing twelve-month return on equity of 12.25%.

What guidance has Nature's Sunshine Products issued on next quarter's earnings?

Nature's Sunshine Products issued an update on its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $455.0 million-$480.0 million, compared to the consensus revenue estimate of $464.3 million.

What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO?

13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com . Terrence Moorehead has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Nature's Sunshine Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD) , Gilead Sciences (GILD) , Pfizer (PFE) , AT&T (T) , AbbVie (ABBV) , Akorn (AKRX) , Bausch Health Companies (BHC) , Catalyst Pharmaceuticals (CPRX) , Exelixis (EXEL) and Global Blood Therapeutics (GBT) .

Who are Nature's Sunshine Products' major shareholders?

Nature's Sunshine Products' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wasatch Advisors LP (2.75%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap. View institutional ownership trends .

How do I buy shares of Nature's Sunshine Products?

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NATR

Nature's Sunshine Products (NATR) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free NATR Stock Alerts

$19.29

+0.59 (+3.16%)

(As of 04/19/2024 ET)

Compare

Today's Range: $18.73
▼
$19.48
50-Day Range: $17.20
▼
$20.87
52-Week Range: $10.06
▼
$21.72

Volume: 47,212 shs
Average Volume: 51,149 shs
Market Capitalization: $363.04 million

P/E Ratio: 25.05
Dividend Yield: N/A
Price Target: $24.00

Get Nature's Sunshine Products alerts:

Nature's Sunshine Products MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 24.4% Upside
$24.00 Price Target
Short Interest: Healthy
0.60% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.50 out of 5 stars

Medical Sector

449th out of 911 stocks

Pharmaceutical Preparations Industry

199th out of 411 stocks

2.5

Analyst's Opinion

Consensus Rating
Nature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Nature's Sunshine Products has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.60% of the float of Nature's Sunshine Products has been sold short.
Short Interest Ratio / Days to Cover
Nature's Sunshine Products has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Nature's Sunshine Products has recently decreased by 8.91%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Nature's Sunshine Products does not currently pay a dividend.
Dividend Growth
Nature's Sunshine Products does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NATR.

0.0

News and Social Media Coverage

Search Interest
Only 2 people have searched for NATR on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Nature's Sunshine Products to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nature's Sunshine Products insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.70% of the stock of Nature's Sunshine Products is held by insiders.
Percentage Held by Institutions
79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Nature's Sunshine Products is 25.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.09.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nature's Sunshine Products is 25.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 227.14.
Price to Book Value per Share Ratio
Nature's Sunshine Products has a P/B Ratio of 2.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Nature's Sunshine Products Stock (NASDAQ:NATR)

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

NATR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NATR Stock News Headlines

April 4, 2024 | finance.yahoo.com

Nature's Sunshine Products, Inc.'s (NASDAQ:NATR) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

March 15, 2024 | finance.yahoo.com

Nature's Sunshine Products, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

March 14, 2024 | marketwatch.com

Nature's Sunshine Shares Touch 52-Week High After 4Q Update

March 13, 2024 | finance.yahoo.com

Why Nature's Sunshine (NATR) Stock Is Up Today

March 13, 2024 | finanznachrichten.de

Nature's Sunshine Products, Inc.: Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial Results

March 12, 2024 | finance.yahoo.com

Nature's Sunshine (NASDAQ:NATR) Misses Q4 Sales Targets

March 12, 2024 | gurufocus.com

Nature's Sunshine Products Inc (NATR) Reports Significant Growth in Q4 and Full Year 2023 Earnings

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 12, 2024 | globenewswire.com

Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial Results

March 11, 2024 | benzinga.com

Preview: Natures Sunshine Products's Earnings

March 11, 2024 | finance.yahoo.com

Nature's Sunshine (NATR) Q4 Earnings: What To Expect

February 20, 2024 | finance.yahoo.com

Nature’s Sunshine Sets Fourth Quarter and Full Year 2023 Conference Call for Tuesday, March 12, 2024, at 5:00 p.m. ET

February 20, 2024 | globenewswire.com

Nature's Sunshine Sets Fourth Quarter and Full Year 2023 Conference Call for Tuesday, March 12, 2024, at 5:00 p.m. ET

February 6, 2024 | finance.yahoo.com

Is There Now An Opportunity In Nature's Sunshine Products, Inc. (NASDAQ:NATR)?

January 31, 2024 | seekingalpha.com

Nature's Sunshine Products: Unconvincing Trajectory Despite Improvements

January 2, 2024 | finance.yahoo.com

Nature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024

December 21, 2023 | finance.yahoo.com

Nature's Sunshine Products, Inc. (NASDAQ:NATR) is definitely on the radar of institutional investors who own 39% of the company

December 19, 2023 | finance.yahoo.com

Nature’s Sunshine Recognized with Best Company Culture Award

December 12, 2023 | benzinga.com

Natures Sunshine Products Stock (NASDAQ:NATR), Quotes and News Summary

November 27, 2023 | msn.com

Nature`s Sunshine Products (NATR) Price Target Increased by 10.26% to 21.93

November 23, 2023 | finance.yahoo.com

The Return Trends At Nature's Sunshine Products (NASDAQ:NATR) Look Promising

November 9, 2023 | finance.yahoo.com

Investing in Nature's Sunshine Products (NASDAQ:NATR) a year ago would have delivered you a 108% gain

November 8, 2023 | morningstar.com

Natures Sunshine Products Inc NATR

November 8, 2023 | finance.yahoo.com

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q3 2023 Earnings Call Transcript

November 7, 2023 | finance.yahoo.com

Nature's Sunshine Reports Strong Third Quarter 2023 Results

October 24, 2023 | finance.yahoo.com

Nature’s Sunshine Sets Third Quarter 2023 Conference Call for Tuesday, November 7, 2023, at 5:00 p.m. ET

See More Headlines

Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/12/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: Personal Products
Current Symbol: NASDAQ:NATR
CUSIP: 63902710
CIK: 275053
Web: www.naturessunshine.com
Phone: (801) 341-7900
Fax: 801-342-4305
Employees: 814
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $24.00
High Stock Price Target: $24.00
Low Stock Price Target: $24.00
Potential Upside/Downside: +25.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.77
Trailing P/E Ratio: 24.79
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $15.08 million
Net Margins: 3.39%
Pretax Margin: 4.54%
Return on Equity: 12.25%
Return on Assets: 7.75%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.16
Quick Ratio: 1.29

Sales & Book Value

Annual Sales: $445.32 million
Price / Sales: 0.81
Cash Flow: $1.62 per share
Price / Cash Flow: 11.79
Book Value: $8.36 per share
Price / Book: 2.28

Miscellaneous

Outstanding Shares: 18,820,000
Free Float: 17,935,000
Market Cap: $359.27 million
Optionable: Optionable
Beta: 0.82

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Terrence O. Moorehead (Age 60)
President, CEO & Director
Comp: $2.12M
Mr. L. Shane Jones (Age 53)
Executive VP, CFO & Treasurer
Comp: $1.01M
Mr. Martin Gonzalez (Age 54)
Executive Vice President of Global Supply Chain Operations
Comp: $690.73k
Trent McCausland
Executive Director, Head of Operations & COO
Mr. Nathan G. Brower (Age 43)
Executive VP, General Counsel & Secretary
Ms. Sarah Crockett (Age 41)
Global Chief Marketing Officer
Ms. Tracee Comstock (Age 57)
Vice President of Human Resources
Mr. Bryant J. Yates (Age 51)
Executive VP & President of Europe
Comp: $496.15k
Mr. Daniel C. Norman (Age 49)
Executive VP & President of Asia/Pacific (APAC)
Comp: $574.31k
Mr. Kevin R. Herbert (Age 57)
Executive VP & President of North America

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NATR Stock Analysis - Frequently Asked Questions

Should I buy or sell Nature's Sunshine Products stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NATR shares.
View NATR analyst ratings or view top-rated stocks.
What is Nature's Sunshine Products' stock price target for 2024?: 1 Wall Street analysts have issued 12 month price objectives for Nature's Sunshine Products' shares. Their NATR share price targets range from $24.00 to $24.00. On average, they predict the company's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 24.4% from the stock's current price.
View analysts price targets for NATR or view top-rated stocks among Wall Street analysts.
How have NATR shares performed in 2024?: Nature's Sunshine Products' stock was trading at $17.29 at the start of the year. Since then, NATR stock has increased by 11.6% and is now trading at $19.29.
View the best growth stocks for 2024 here.
When is Nature's Sunshine Products' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our NATR earnings forecast.
How were Nature's Sunshine Products' earnings last quarter?: Nature's Sunshine Products, Inc. (NASDAQ:NATR) released its quarterly earnings data on Tuesday, March, 12th. The company reported $0.45 earnings per share (EPS) for the quarter. The company had revenue of $108.94 million for the quarter. Nature's Sunshine Products had a net margin of 3.39% and a trailing twelve-month return on equity of 12.25%.
What guidance has Nature's Sunshine Products issued on next quarter's earnings?: Nature's Sunshine Products issued an update on its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $455.0 million-$480.0 million, compared to the consensus revenue estimate of $464.3 million.

What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO?: 13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among the company's employees.
What other stocks do shareholders of Nature's Sunshine Products own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT).
Who are Nature's Sunshine Products' major shareholders?: Nature's Sunshine Products' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wasatch Advisors LP (2.75%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap.
View institutional ownership trends.
How do I buy shares of Nature's Sunshine Products?: Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NATR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial